ES2070307T3 - Una preparacion para el tratamiento de la hipertension. - Google Patents

Una preparacion para el tratamiento de la hipertension.

Info

Publication number
ES2070307T3
ES2070307T3 ES90850263T ES90850263T ES2070307T3 ES 2070307 T3 ES2070307 T3 ES 2070307T3 ES 90850263 T ES90850263 T ES 90850263T ES 90850263 T ES90850263 T ES 90850263T ES 2070307 T3 ES2070307 T3 ES 2070307T3
Authority
ES
Spain
Prior art keywords
polymeric substance
hypertension
vitamin
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90850263T
Other languages
English (en)
Inventor
Marcin Krotkiewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2070307T3 publication Critical patent/ES2070307T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

ES UNA PREPARACION ANTIHIPERTENSA QUE CONTIENE UNA SUSTANCIA POLIMERICA CON PROPIEDADES ENLAZANTES, POR EJEMPLO, UN POLISACARIDO O SIMILAR Y VITAMINA D O DERIVADOS/ANALOGOS DE ELLA. SE PREFIERE COMO SUSTANCIA POLIMERICA LA ALGITINA OBTENIDA DE FIBRAS DE ALGA. LA VITAMINA D EJERCE EFECTOS SINERGETICOS CON RESPECTO A LA DISMINUCION DE LA PRESION SANGUINEA PROVOCADA POR LA SUSTANCIA POLIMERICA EN PACIENTES CON HIPERTENSION LEVE.
ES90850263T 1990-07-04 1990-07-04 Una preparacion para el tratamiento de la hipertension. Expired - Lifetime ES2070307T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90850263A EP0464299B1 (en) 1990-07-04 1990-07-04 Antihypertensive preparation

Publications (1)

Publication Number Publication Date
ES2070307T3 true ES2070307T3 (es) 1995-06-01

Family

ID=8206056

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90850263T Expired - Lifetime ES2070307T3 (es) 1990-07-04 1990-07-04 Una preparacion para el tratamiento de la hipertension.

Country Status (6)

Country Link
US (1) US5141927A (es)
EP (1) EP0464299B1 (es)
JP (1) JP3048380B2 (es)
AT (1) ATE116859T1 (es)
DE (1) DE69016014T2 (es)
ES (1) ES2070307T3 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460957A (en) * 1992-04-28 1995-10-24 Maruha Corporation Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
US5354743A (en) * 1992-09-15 1994-10-11 Thys Jacobs Susan Method for the treatment of premenstrual syndrome with vitamin D
JP3331269B2 (ja) * 1994-12-02 2002-10-07 京三電機株式会社 止め弁の構造
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
TWI268138B (en) 2000-05-11 2006-12-11 Kanebo Seiyaku Ltd Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
JP2002061765A (ja) 2000-06-08 2002-02-28 Toyoda Gosei Co Ltd 燃料遮断弁
JP2002154977A (ja) * 2000-09-05 2002-05-28 Kao Corp 飲食用組成物
WO2005011660A1 (en) * 2003-07-29 2005-02-10 Abbott Laboratories Use of vitamin d to down regulate the renin-angiotensin-aldosterone system
US8282960B2 (en) * 2004-03-30 2012-10-09 Relypsa, Inc. Ion binding compositions
DE112005000708B4 (de) * 2004-03-30 2017-12-21 Relypsa, Inc. (n.d.Ges.d. Staates Delaware) Ionen bindende Zusammensetzung
CA2557848C (en) * 2004-03-30 2013-12-10 Ilypsa, Inc. Ion binding compositions
US8192758B2 (en) * 2004-03-30 2012-06-05 Relypsa, Inc. Ion binding compositions
US7556799B2 (en) * 2004-03-30 2009-07-07 Relypsa, Inc. Ion binding polymers and uses thereof
US7854924B2 (en) * 2004-03-30 2010-12-21 Relypsa, Inc. Methods and compositions for treatment of ion imbalances
US7429394B2 (en) * 2004-03-30 2008-09-30 Relypsa, Inc. Ion binding compositions
ES2347058T3 (es) * 2004-11-22 2010-10-25 Wisconsin Alumni Research Foundation 2-metilen-19-nor-1(alfha)-hydroxy-17-eno-hemopregnacalciferol y sus usos.
CA2624112A1 (en) * 2005-09-30 2007-04-05 Ilypsa, Inc. Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
BRPI0616604A2 (pt) 2005-09-30 2012-12-25 Ilypsa Inc mÉtodo para remover e composiÇço para seletivamente remover Íon de potÁssio do trato gastrintestinal de um mamÍfero, mÉtodo para seletivamente remover Íon de potÁssio de um meio-ambiente, composiÇço farmacÊutica, partÍcula de nécleo-envoltàrio, e, usos de uma partÍcula de nécleo-envoltàrio e de uma composiÇço farmacÊutica
US10716798B2 (en) * 2007-02-21 2020-07-21 The Regents Of The University Of Michigan Compositions and methods for tranquilizing heart muscle
EP2431043A1 (en) 2007-05-23 2012-03-21 Amcol International Corporation Cholesterol-interacting layered phyllosilicates for suppressing gastrointestinal cholesterol absorption
US20090060943A1 (en) * 2007-08-31 2009-03-05 O'mara Brendan Joseph Syndrome X Composition and Method of Lowering Blood Pressure and Glycemic Index
WO2010022380A2 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Linear polyol stabilized polyfluoroacrylate compositions
WO2010022381A1 (en) * 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
WO2010022383A2 (en) * 2008-08-22 2010-02-25 Relypsa, Inc. Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia
KR20150088243A (ko) 2012-10-08 2015-07-31 리립사, 인크. 고혈압 및 고칼륨혈증을 치료하기 위한 칼륨-결합제
CN103083483B (zh) * 2013-01-30 2015-07-01 中国中医科学院中医临床基础医学研究所 一种治疗1、2级高血压病的中药组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1070910B (de) * 1959-12-10 zugll Verfahren zur Herstellung von Alginsäure hohen Reinheitsgrades
GB760030A (en) * 1952-12-05 1956-10-31 Henkel & Cie Gmbh Process for the manufacture of dispersive, water-soluble alginates with high solubility speed
SU589956A1 (ru) * 1976-01-12 1978-01-30 Полярный Научно-Исследовательский И Проектный Институт Морского Рыбного Хозяйства И Океанографии Им. Н.М.Книповича Способ очистки растворов от примесей
JPS60206801A (ja) * 1984-03-30 1985-10-18 Kimitsu Kagaku Kenkyusho:Kk 有機溶剤可溶性アルギン酸の製造方法
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
US4804536A (en) * 1985-06-13 1989-02-14 Shimizu Kagaku Kabushiki Kaisha Dietary fibres of seaweed having ion-exchange ability
FR2584410B1 (fr) * 1985-07-05 1987-11-27 Inst Nal Polytechnique Procede d'obtention d'agar-agar a partir de jus d'extraction d'algues
FR2592383B1 (fr) * 1985-12-26 1990-01-19 Adeline Andre Procede de preparation d'un film souple d'alginate de calcium
US4840894A (en) * 1986-03-04 1989-06-20 The Trustees Of Columbia University In The City Of New York Method for detecting a marker for essential hypertension and diagnostic use thereof
JPH0764804B2 (ja) * 1986-04-25 1995-07-12 住友製薬株式会社 活性型ビタミンｄ３のフッ素誘導体
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
US4797300A (en) * 1987-04-10 1989-01-10 The Procter & Gamble Company Compositions containing novel solid, nondigestible, fat-like compounds
US4962092A (en) * 1987-05-06 1990-10-09 The Procter & Gamble Company Compositions for treating duodenal ulcers
DE3865544D1 (de) * 1987-06-23 1991-11-21 Yamanouchi Pharma Co Ltd Vitamin d3-derivate.
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US4983268A (en) * 1989-08-03 1991-01-08 Fmc Corporation High gel strength low electroendosmosis agarose

Also Published As

Publication number Publication date
DE69016014T2 (de) 1995-08-31
US5141927A (en) 1992-08-25
JPH0474124A (ja) 1992-03-09
ATE116859T1 (de) 1995-01-15
DE69016014D1 (de) 1995-02-23
JP3048380B2 (ja) 2000-06-05
EP0464299A1 (en) 1992-01-08
EP0464299B1 (en) 1995-01-11

Similar Documents

Publication Publication Date Title
ES2070307T3 (es) Una preparacion para el tratamiento de la hipertension.
DE69530389D1 (de) Dexanabinol-derivate und ihre verwendung als neuroprotektive pharmazeutische zusammensetzungen
KR920702682A (ko) 1, 3-옥사티오란 뉴클레오시드 동족체
KR920021555A (ko) 비사이클릭 라파 마이신
DE69719931T2 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
ATE222759T1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
EA200001191A1 (ru) Новые фармацевтические композиции для лечения и жизнеобеспечения (поддержания жизненных функций) и способ их приготовления
DK0448765T3 (da) Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
DE58902712D1 (de) N-acetylglucosamin-zubereitungen zur buccalen anwendung.
BR9406059A (pt) Composição farmacéutica e método para tratamento de uma infecção helmintica em um animal
KR927003525A (ko) 술폰아닐리드 유도체 및 의약
RS52011B (sr) Nova primena derivata taksoida
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
DE60106953D1 (de) Adenosinderivate und deren verwendung
EP0429522A4 (en) Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
SE8704979L (sv) Nya furanuronsyraderivat, forfarande for deras framstellning och deras anvendning
AU2979899A (en) Treatment of viral disease in swine
ES2062120T3 (es) Nuevas n-(aril substituido)-n'-(alcoxi substituido)-ureas y tioureas como agentes anticolesterolemicos y antiateroscleroticos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464299

Country of ref document: ES